1
|
Fan J. Entrepreneurial Mentality Analysis for College Students Based on the Improved BP Neural Network. JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH 2022; 2022:1556489. [PMID: 35983509 PMCID: PMC9381275 DOI: 10.1155/2022/1556489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Revised: 06/13/2022] [Accepted: 06/18/2022] [Indexed: 11/17/2022]
Abstract
In this study, the fuzzy comprehensive evaluation model is used to evaluate the characteristics of college students' entrepreneurial psychology, and a prediction model of college students' entrepreneurial psychology characteristics is established, which is simulated by Matlab to achieve good validity. Based on the research on the characteristics of college students' entrepreneurial psychology, this study proposes a design method of indicators and parameters for evaluating the characteristics of college students' entrepreneurial psychology. In this study, the genetic algorithm is used to optimize the BP neural network. The optimized neural network greatly improves the global search and local search capabilities. The performance of the model is tested through simulation tests. Through the simulation comparison test between the improved model and the standard model, the results show that the model can predict the entrepreneurial psychological characteristics of college students. By comparing the improved BP neural network algorithm with the original algorithm simulation experiment, the improved BP neural network improves the sensitivity by 20%, the specificity by 5%, and the accuracy by 8%.
Collapse
Affiliation(s)
- Jinling Fan
- Hebei Normal University, Hebei University of Science and Technology, Shijiazhuang 050000, Hebei, China
| |
Collapse
|
2
|
Deaths from total and premature cardiovascular disease associated with high normal blood pressure and hypertension in rural Chinese men and elderly people. J Hum Hypertens 2020; 35:741-750. [PMID: 32690863 DOI: 10.1038/s41371-020-0379-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 06/24/2020] [Accepted: 07/07/2020] [Indexed: 11/12/2022]
Abstract
To investigate the association of blood pressure (BP) categories with total and premature cardiovascular disease (CVD) mortality in rural Chinese. The study included 14,539 adults ≥18 years in rural China. Baseline study visits were conducted in 2007-2008, and follow-up visits in 2013-2014. Data were collected by face-to-face questionnaire interview, and anthropometric and laboratory measurements. A sub-distribution hazards model was used to calculate adjusted sub-distribution hazard ratios (aSHRs) and 95% confidence intervals (CIs). During the 6-year follow-up, 257 total and 209 premature CVD deaths occurred. As compared with normal BP (systolic BP/diastolic BP (SBP/DBP) < 120/80 mmHg), for men and people aged ≥60 years, hypertension (SBP/DBP ≥ 140/90 mmHg) associated with total CVD mortality (aSHR 3.57, 95% CI 2.06-6.17; aSHR 2.15, 1.29-3.56) and premature CVD mortality (aSHR 4.41, 2.37-8.21; aSHR 2.31, 1.27-4.19). Also, as compared with normal BP, for men and people aged ≥60 years with high normal BP (SBP/DBP 120-139/80-89 mmHg), risk of total CVD mortality increased (aSHR 1.85, 1.05-3.28; aSHR 1.78, 1.05-3.04), as was premature CVD mortality (aSHR 1.89, 0.99-3.64; aSHR 1.91, 1.03-3.54). Among men and people aged ≥60 years in rural China, risk of total and premature CVD mortality was increased for those with high normal BP and hypertension. Prevention and treatment strategies for additional CVD risk reduction targeting men and elderly people with hypertension or even high normal BP are needed to reduce CVD mortality risk.
Collapse
|
3
|
Liu L, Wang B, Liu X, Ren Y, Zhao Y, Liu D, Zhou J, Liu X, Zhang D, Chen X, Cheng C, Liu F, Zhou Q, Li J, Cao J, Chen J, Huang J, Zhang M, Hu D. Sex-Specific Association of Blood Pressure Categories With All-Cause Mortality: The Rural Chinese Cohort Study. Prev Chronic Dis 2020; 17:E09. [PMID: 31999540 PMCID: PMC6993785 DOI: 10.5888/pcd17.190131] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Introduction The relationship between blood pressure categories and all-cause mortality has not been fully addressed in cohort studies, especially in the general Chinese population. Our study aimed to assess the sex-specific association of systolic blood pressure (SBP), diastolic blood pressure (DBP), and 2017 United States hypertension guidelines with all-cause mortality in China. Methods We conducted a prospective study of 13,760 rural Chinese adults aged 18 or older (41.1% men). Mean age overall was 49.4, 51.0 for men, and 48.3 for women. We analyzed the blood pressure–mortality relationship by using restricted cubic splines and Cox proportional-hazards regression analysis, estimating hazard ratios (HRs) and 95% confidence intervals (CIs). Results During a mean follow-up of 5.95 years, 710 people died (60.3% men) from any cause. We found a U-shaped SBP–mortality or DBP–mortality relationship for both sexes. Mortality risk was increased for men with SBP 120–139 mm Hg (adjusted HR [aHR], 1.42; 95% CI, 1.10–1.82) or ≥140 mm Hg (aHR, 2.05; 95% CI, 1.54–2.72), and for DBP ≥90 mm Hg (aHR, 1.53; 95% CI, 1.10–2.13) as compared with SBP 100–119 mm Hg or DBP 70–79 mm Hg. Mortality risk also was increased for men with blood pressure status defined according to 2017 US hypertension guidelines as elevated, SBP 120–129 and DBP >80 mm Hg (aHR 1.48; 95% CI,1.11–1.98); stage 1 hypertension, SBP/DBP 130–139/80–89 mm Hg (aHR 1.53; CI, 1.19–1.97); and stage 2 hypertension, SBP/DBP ≥140/90 mm Hg (aHR 1.83; CI, 1.33–2.51). No significant relationship was observed for women. Conclusion Elevated blood pressure and stages 1 and 2 hypertension were positively associated with all-cause mortality for men but not women in rural China.
Collapse
Affiliation(s)
- Leilei Liu
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China
| | - Bingyuan Wang
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.,Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Xincan Liu
- Department of Cardiology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China
| | - Yongcheng Ren
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.,Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Yang Zhao
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.,Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Dechen Liu
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.,Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Junmei Zhou
- Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Xuejiao Liu
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China
| | - Dongdong Zhang
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China
| | - Xu Chen
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China
| | - Cheng Cheng
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China
| | - Feiyan Liu
- Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Qionggui Zhou
- Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Jianxin Li
- Study Team of Shenzhen's Sanming Project, The Affiliated Luohu Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China.,Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
| | - Jie Cao
- Study Team of Shenzhen's Sanming Project, The Affiliated Luohu Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China.,Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
| | - Jichun Chen
- Study Team of Shenzhen's Sanming Project, The Affiliated Luohu Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China.,Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
| | - Jianfeng Huang
- Study Team of Shenzhen's Sanming Project, The Affiliated Luohu Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China.,Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
| | - Ming Zhang
- Department of Preventive Medicine, Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China
| | - Dongsheng Hu
- Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China. E-mail:
| |
Collapse
|
4
|
Robles NR, Fici F, Grassi G. J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure? J Nephrol 2018; 32:347-353. [PMID: 30225803 DOI: 10.1007/s40620-018-0535-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Accepted: 08/31/2018] [Indexed: 12/21/2022]
Abstract
Aggressive reduction of blood pressure (BP) may increase cardiovascular events (the J-curve phenomenon) in certain populations. There is a high number of available studies of antihypertensive treatment that provide strong evidence for J-shaped relationships between both diastolic and systolic BP and main cardiovascular outcomes. Nonetheless, most available studies were observational, and randomized trials might not have or lost their statistical power in post-hoc analysis. Contrariwise, most of prospective trial to demonstrate the benefits of intensive blood pressure control were inconclusive. Therefore, further studies are still necessary in order to clarify this issue.
Collapse
Affiliation(s)
- Nicolás Roberto Robles
- Unidad de Hipertensión, Hospital Infanta Cristina, Carretera de Portugal s/n, 06070, Badajoz, Spain. .,University of Salamanca School of Medicine, Salamanca, Spain.
| | - Francesco Fici
- Unidad de Hipertensión, Hospital Infanta Cristina, Carretera de Portugal s/n, 06070, Badajoz, Spain.,University of Salamanca School of Medicine, Salamanca, Spain.,University of Salamanca School of Medicine, Salamanca, Spain
| | - Guido Grassi
- Clinica Medica, Università Milano-Bicocca, Milan, Italy.,IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy
| |
Collapse
|
5
|
Kovesdy CP. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties. Nephrol Dial Transplant 2017; 32:ii219-ii223. [PMID: 28201651 DOI: 10.1093/ndt/gfw269] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2016] [Accepted: 06/12/2016] [Indexed: 11/13/2022] Open
Abstract
Hypertension is the number one cardiovascular (CV) risk factor, and its treatment represents one of the most important interventions in patients at high risk for CV events. Patients with chronic kidney disease (CKD) are at high CV risk, yet as a group they have been excluded from most major blood pressure (BP)-lowering trials examining CV and mortality end points. The paucity of randomized clinical trial evidence for BP lowering in CKD patients is compounded by the fact that the association between BP levels and clinical outcomes in patients with CKD suggests the presence of a J-curve, which makes extrapolations from general population studies especially difficult. The recent completion of the Systolic Blood Pressure Intervention Trial (SPRINT), which enrolled a large number of patients with mild to moderate CKD, has raised hope for much-needed clarity about the ideal systolic BP target in this patient population. This review discusses the epidemiology of hypertension in CKD and the pathophysiologic underpinnings of the distinct associations between BP levels and clinical outcomes in patients with CKD, and it examines the applicability of the SPRINT results to the general CKD population.
Collapse
Affiliation(s)
- Csaba P Kovesdy
- Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA.,Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, TN, USA
| |
Collapse
|
6
|
Robles NR, Hernandez-Gallego R, Fici F, Grassi G. Does a blood pressure J curve exist for patients with chronic kidney disease? J Clin Hypertens (Greenwich) 2017; 19:764-770. [DOI: 10.1111/jch.13024] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Revised: 03/21/2017] [Accepted: 03/26/2017] [Indexed: 01/13/2023]
Affiliation(s)
| | | | - Francesco Fici
- Clinica Medica; Ospedale San Gerardo; Università Milano-Bicocca; Monza Italy
| | - Guido Grassi
- Clinica Medica; Università Milano-Bicocca and IRCCS MultiMedica; Sesto San Giovanni Milan Italy
| |
Collapse
|
7
|
Svensson MK, Afghahi H, Franzen S, Björk S, Gudbjörnsdottir S, Svensson AM, Eliasson B. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register. Diab Vasc Dis Res 2017; 14:226-235. [PMID: 28467201 DOI: 10.1177/1479164116683637] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
BACKGROUND Previous studies have shown a U-shaped relationship between systolic blood pressure and risk of all-cause of mortality in patients with type 2 diabetes and renal impairment. AIMS To evaluate the associations between time-updated systolic blood pressure and time-updated change in systolic blood pressure during the follow-up period and risk of all-cause mortality in patients with type 2 diabetes and renal impairment. PATIENTS AND METHODS A total of 27,732 patients with type 2 diabetes and renal impairment in the Swedish National Diabetes Register were followed for 4.7 years. Time-dependent Cox models were used to estimate risk of all-cause mortality. Time-updated mean systolic blood pressure is the average of the baseline and the reported post-baseline systolic blood pressures. RESULTS A time-updated systolic blood pressure < 130 mmHg was associated with a higher risk of all-cause mortality in patients both with and without a history of chronic heart failure (hazard ratio: 1.25, 95% confidence interval: 1.13-1.40 and hazard ratio: 1.26, 1.17-1.36, respectively). A time-updated decrease in systolic blood pressure > 10 mmHg between the last two observations was associated with higher risk of all-cause mortality (-10 to -25 mmHg; hazard ratio: 1.24, 95% confidence interval: 1.17-1.32). CONCLUSION Both low systolic blood pressure and a decrease in systolic blood pressure during the follow-up are associated with a higher risk of all-cause mortality in patients with type 2 diabetes and renal impairment.
Collapse
Affiliation(s)
- Maria K Svensson
- 1 Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
| | - Henri Afghahi
- 2 Department of Nephrology, Skaraborg Hospital, Skövde, Sweden
| | - Stefan Franzen
- 3 Centre of Registers Västra Götaland, Gothenburg, Sweden
| | - Staffan Björk
- 3 Centre of Registers Västra Götaland, Gothenburg, Sweden
| | | | | | - Björn Eliasson
- 4 Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
| |
Collapse
|
8
|
Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Drueke TB, Massy ZA, Stengel B. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney Int Rep 2017; 2:180-191. [PMID: 29142956 PMCID: PMC5678838 DOI: 10.1016/j.ekir.2016.10.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2016] [Revised: 10/15/2016] [Accepted: 10/25/2016] [Indexed: 01/10/2023] Open
Abstract
INTRODUCTION Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies the effect of hypertension control on outcomes is unknown. METHODS We studied 10-year mortality and cardiovascular events according to hypertension control status and CKD (glomerular filtration rate <60 ml/min/1.73m2) in 4262 community-dwelling individuals (40% men) more than 65 years of age. RESULTS At baseline, 19% had CKD, and 31.2% had controlled hypertension on ≤3 antihypertensive drugs, 62.3% uncontrolled hypertension ≥140/90 mm Hg on ≤2 drugs, and 6.5% apparent treatment-resistant hypertension (aTRH) ≥140/90 mm Hg with ≥3 drugs or use of ≥4 drugs regardless of level. There were 1115 deaths (305 total cardiovascular deaths) and 274 incident nonfatal or fatal strokes or coronary events. Compared to the reference group (controlled hypertension and no CKD), participants without CKD and with uncontrolled hypertension or aTRH had adjusted hazard ratios for all-cause mortality of 0.86 (0.74-1.01) and 1.09 (0.82-1.46), and those with CKD and controlled or uncontrolled hypertension, or aTRH, of 1.33 (1.06-1.68), 1.14 (0.93-1.39), and 1.34 (0.98-1.85), respectively. Participants with aTRH and CKD had a risk of coronary death more than 3 times higher than that of the reference group; participants with aTHR, with or without CKD, had a risk of stroke more than twice as high, and those with CKD but controlled hypertension a 2 times higher risk for cardiovascular deaths from other causes. DISCUSSION CKD does not appear to amplify the risk of stroke and coronary events associated with aTRH in this older population. The reasons for excess cardiovascular mortality from other causes associated with controlled hypertension require further study.
Collapse
Affiliation(s)
- Jean Kaboré
- CESP, Inserm UMR1018 Team 5, University of Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France
| | - Marie Metzger
- CESP, Inserm UMR1018 Team 5, University of Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France
| | - Catherine Helmer
- Inserm, UMR1219 Population Health, Bordeaux, France
- University of Bordeaux, UMR1219, Bordeaux, France
- Clinical Investigation Center—Clinical Epidemiology 1401, Bordeaux, France
| | - Claudine Berr
- Inserm U1061, Montpellier, France
- University Montpellier I, Montpellier, France
| | - Christophe Tzourio
- Inserm, UMR1219 Population Health, Bordeaux, France
- University of Bordeaux, UMR1219, Bordeaux, France
| | - Tilman B. Drueke
- CESP, Inserm UMR1018 Team 5, University of Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France
| | - Ziad A. Massy
- CESP, Inserm UMR1018 Team 5, University of Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France
- Division of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, France
| | - Bénédicte Stengel
- CESP, Inserm UMR1018 Team 5, University of Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France
| |
Collapse
|
9
|
Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med 2013; 159:233-42. [PMID: 24026256 PMCID: PMC4155539 DOI: 10.7326/0003-4819-159-4-201308200-00004] [Citation(s) in RCA: 163] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND The ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-dependent chronic kidney disease (CKD) is unclear. OBJECTIVE To assess the association of BP (defined as the combination of systolic BP [SBP] and diastolic BP [DBP] at the individual level) with death in patients with CKD. DESIGN Historical cohort between 2005 and 2012. SETTING All U.S. Department of Veterans Affairs health care facilities. PATIENTS 651 749 U.S. veterans with CKD. MEASUREMENTS All possible combinations of SBP and DBP were examined in 96 categories from lowest (<80/<40 mm Hg) to highest (>210/>120 mm Hg), in 10-mm Hg increments. Associations with all-cause mortality were examined in time-dependent Cox models with adjustment for relevant confounders. RESULTS Patients with SBP of 130 to 159 mm Hg combined with DBP of 70 to 89 mm Hg had the lowest adjusted mortality rates, and those in whom both SBP and DBP were concomitantly very high or very low had the highest mortality rates. Patients with moderately elevated SBP combined with DBP no less than 70 mm Hg had consistently lower mortality rates than did patients with ideal SBP combined with DBP less than 70 mm Hg. Results were consistent in subgroups of patients with normal and elevated urinary microalbumin-creatinine ratios. LIMITATION Mostly male patients, inability to establish causality, and large number of patients missing proteinuria measurement. CONCLUSION The optimal BP in patients with CKD seems to be 130 to 159/70 to 89 mm Hg. It may not be advantageous to achieve ideal SBP at the expense of lower-than-ideal DBP in adults with CKD. PRIMARY FUNDING SOURCE National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and U.S. Department of Veterans Affairs.
Collapse
|
10
|
Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, Ueshima H. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res 2012; 35:947-53. [PMID: 22739419 DOI: 10.1038/hr.2012.87] [Citation(s) in RCA: 114] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Blood pressure (BP) categories defined by systolic BP (SBP) and diastolic BP (DBP) are commonly used. However, the BP category-specific risk of cardiovascular disease (CVD) has not been thoroughly investigated in different age groups. The aim of this study was to assess long-term CVD risk and its impact according to BP categories and age group. Pooling individual data from 10 cohorts, we studied 67 309 Japanese individuals (40-89 years old) who were free of CVD at baseline: we categorized them as belonging to three age groups: 'middle-aged' (40-64 years), 'elderly' (65-74 years) and 'very elderly' (75-89 years). BP was classified according to the 2009 Japanese Society of Hypertension Guidelines. Cox models were used to estimate adjusted hazard ratios for CVD deaths. We observed 1944 CVD deaths over a mean follow-up of 10.2 years. In all age groups, the overall relationship between BP category and CVD risk was positive, with a greater strength observed for younger age groups. We observed a trend of increased risk from SBP/DBP ≥ 130/85 mm Hg in the very elderly, and a significant increase from SBP/DBP ≥ 120/80 mm Hg in the other age groups. The population attributable fractions (PAFs) of CVD death in reference to the SBP/DBP<120/80 mm Hg category ranged from 23.4% in the very elderly to 60.3% in the middle-aged. We found an overall graded increase in CVD risk with higher BP category in the very elderly. The PAFs suggest that keeping BP levels low is an important strategy for primary CVD prevention, even in an elderly population.
Collapse
Affiliation(s)
- Akira Fujiyoshi
- Department of Health Science, Shiga University of Medical Science, Otsu, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Pinna G, Pascale C. La curva J nell’ipertensione. Speculazione fisiopatologica o problematica necessaria nella pratica clinica? ITALIAN JOURNAL OF MEDICINE 2011. [DOI: 10.1016/j.itjm.2010.09.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
12
|
Izzo JL. Are There Benefits of Antihypertensive Therapy Beyond Blood Pressure Lowering? Curr Hypertens Rep 2010; 12:440-7. [DOI: 10.1007/s11906-010-0160-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
13
|
Raiszadeh F, Travin MI. Are people with normal radionuclide perfusion imaging studies better-off if they are obese? J Nucl Cardiol 2010; 17:350-3. [PMID: 20379860 DOI: 10.1007/s12350-010-9227-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol 2009; 54:1827-34. [PMID: 19892233 DOI: 10.1016/j.jacc.2009.05.073] [Citation(s) in RCA: 170] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2008] [Revised: 04/10/2009] [Accepted: 05/06/2009] [Indexed: 01/05/2023]
Abstract
The topic of the J-curve relationship between blood pressure and coronary artery disease (CAD) has been the subject of much controversy for the past decades. An inverse relationship between diastolic pressure and adverse cardiac ischemic events (i.e., the lower the diastolic pressure the greater the risk of coronary heart disease and adverse outcomes) has been observed in numerous studies. This effect is even more pronounced in patients with underlying CAD. Indeed, a J-shaped relationship between diastolic pressure and coronary events was documented in treated patients with CAD in most large trials that scrutinized this relationship. In contrast to any other vascular bed, the coronary circulation receives its perfusion mostly during diastole; hence, an excessive decrease in diastolic pressure can significantly hamper perfusion. This adverse effect of too low a diastolic pressure on coronary heart disease leaves the practicing physician with the disturbing possibility that, in patients at risk, lowering blood pressure to levels that prevent stroke or renal disease might actually precipitate myocardial ischemia. However, these concerns should not deter physicians from pursuing a more aggressive control of hypertension, because currently blood pressure is brought to recommended target levels in only approximately one-third of patients.
Collapse
|
15
|
Blood Pressure Is Lower in Children and Adolescents With a Low-Saturated-Fat Diet Since Infancy. Hypertension 2009; 53:918-24. [DOI: 10.1161/hypertensionaha.109.130146] [Citation(s) in RCA: 78] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Blood pressure was measured in the prospective randomized Special Turku Coronary Risk Factor Intervention Project Study with an oscillometric method every year from 7 months to 15 years of age in 540 children receiving a low-saturated-fat, low-cholesterol diet and in 522 control children. Dietary intakes, family history of parental hypertension, and grandparental vascular disease were recorded. Systolic and diastolic blood pressures were 1.0 mm Hg lower (95% CI for systolic: −1.7 to −0.2 mm Hg; 95% CI for diastolic: −1.5 to −0.4 mm Hg) in children receiving low-saturated-fat counseling through childhood than in control children. Intakes of saturated fat were lower (
P
<0.001), those of polyunsaturated fat higher (
P
<0.001), and intakes of potassium slightly higher (
P
=0.002) in the intervention group, but sodium intakes were not influenced by the intervention (
P
=0.76). Children whose parents were hypertensive had 4- to 6-mm Hg higher systolic and 3- to 4-mm Hg higher diastolic blood pressures than children of normotensive parents (
P
<0.001). Diastolic blood pressure of children with grandparental vascular disease, ie, early cardiovascular or cerebrovascular disease, tended to be higher than that of children with no grandparental disease (
P
=0.051). We conclude that restriction of saturated fat from infancy until 15 years of age decreases childhood and adolescent blood pressure with a meaningful population-attributable amount. The importance of childhood lifestyle counseling and primary prevention of hypertension should be emphasized, especially in those children with a family history of hypertension or atherosclerotic vascular disease.
Collapse
|
16
|
Sugihara M, Miura SI, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res 2009; 32:625-30. [PMID: 19461652 DOI: 10.1038/hr.2009.66] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
This study was performed to evaluate the safety and efficacy of additional antihypertensive therapy with angiotensin II type 1 receptor blocker (ARB; olmesartan or valsartan) after successful stent implantation in patients with coronary artery disease (CAD). Fifty patients with CAD after successful stent implantation were included in this study. They were divided into an ARB group, which initially received olmesartan (n=20, 14+/-8 mg day(-1)) or valsartan (n=20, 60+/-23 mg day(-1)) immediately after stent implantation, and a non-ARB group (n=10) according to their blood pressure (BP). Follow-up coronary angiography, measurement of BP and blood sampling were performed before (at baseline) and 6-8 months after stent implantation (at follow-up). There were no significant differences in the baseline characteristics between the groups, except for BP. Although there were no changes in % diameter restenosis between the groups, the BP level in the ARB group at follow-up showed a significant reduction (125+/-12/69+/-9 mm Hg) and reached the target BP. There were no critical adverse effects in the ARB group throughout the study period. In addition, serum high-sensitive C-reactive protein (hs-CRP) and pentraxin 3 were significantly decreased in the ARB group but not in the non-ARB group. Although olmesartan and valsartan induced similar BP-lowering effects, olmesartan but not valsartan induced a significant decrease in hs-CRP, but did not increase serum uric acid. In conclusion, antihypertensive therapy with add-on low-dose ARB after stent implantation was safe and achieved the target BP. In particular, olmesartan had an anti-inflammatory effect.
Collapse
Affiliation(s)
- Makoto Sugihara
- Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Rivlin RS. Keeping the young-elderly healthy: is it too late to improve our health through nutrition? Am J Clin Nutr 2007; 86:1572S-6S. [PMID: 17991678 DOI: 10.1093/ajcn/86.5.1572s] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Healthy older individuals can take several measures to preserve and improve their health. Even if past nutritional and lifestyle practices were not optimal, much can be done to reduce the risk of chronic disease and disability in future years. The first challenge is to recognize and address the profound changes in body composition that occur with aging. Older persons tend to accumulate relatively more body fat and less lean body mass, ie, muscle and bone. With a gain in body weight, which usually occurs, these changes are exaggerated. Because muscle tissue has a much higher metabolic rate than does fat tissue, older individuals generally develop lower metabolic rates. To avoid excess weight gain, older individuals must make major restrictions in caloric intake and increases in energy expenditure. Women experience changes in body composition similar to those in men, with changes becoming more prominent at menopause. Exercise improves body composition among healthy elderly, both by reducing fat mass and by increasing bone and muscle mass, thereby helping to restore higher metabolic rates. In men and women aged >/=65 y and taking calcium and vitamin D supplements for 3 y, the rate of bone loss slowed and the incidence of nonvertebral fractures was reduced. Several population studies of older persons show that following nutritional and lifestyle guidelines for cancer prevention reduces risk by one-third. Improving serum lipid concentrations in adults over 65 y of age with coronary artery disease decreases the risk of future cardiac events by as much as 45%. Furthermore, the greatest benefit from control of hypertension is in older individuals.
Collapse
Affiliation(s)
- Richard S Rivlin
- Anne Fisher Nutrition Center, Strang Cancer Research Laboratory, New York, NY, USA.
| |
Collapse
|
18
|
Greenberg JA, Fontaine K, Allison DB. Putative biases in estimating mortality attributable to obesity in the US population. Int J Obes (Lond) 2007; 31:1449-55. [PMID: 17471302 DOI: 10.1038/sj.ijo.0803615] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND A recent analysis concluded that there were fewer excess deaths attributable to obesity in the US population than previously believed. This analysis may not have fully corrected for two putative biases, the regression-dilution and the reverse-causation biases. It is not presently known whether correcting for these biases would increase estimates of excess deaths attributable to obesity. METHODS All-cause mortality hazard ratios (HRs) for different body mass index (BMI) categories were calculated and adjusted for confounding factors, using data from the prospective Atherosclerosis Risk in Communities Study. The analysis was based on 12 457 individuals aged 51-70 years and 606 all-cause deaths during a 5.3-year follow-up. The HRs were corrected for the regression-dilution and reverse-causation biases, and compared with data from a previously published study to evaluate the effects of correcting for these putative biases on estimates of excess deaths attributable to obesity in the US population. RESULTS The uncorrected all-cause mortality HR for obesity (BMI>/=30) was 1.26 (95% confidence interval (95% CI)=1.01-1.58), using the 21-25 kg/m(2) as ideal-weight category. Correcting for regression dilution increased the HR to 1.46 (95% CI=1.17-1.83). Correcting for both putative biases increased it further to 2.70 (95% CI=1.31-5.57). Such increases in HRs are consonant with increases of several hundred percent in estimates of deaths attributable to obesity in the US. CONCLUSIONS Correcting for putative biases yielded increases in all-cause mortality HRs for obesity that correspond to substantial increases in estimates of excess deaths attributable to obesity in the US population.
Collapse
Affiliation(s)
- J A Greenberg
- Department of Health and Nutrition Sciences, Brooklyn College of the City University of New York, Brooklyn, NY, USA.
| | | | | |
Collapse
|
19
|
Abstract
OBJECTIVE To assess whether a recent study that found a relatively small number of excess deaths attributable to obesity may have underestimated by not correcting for statistical biases. RESEARCH METHODS AND PROCEDURES This prospective cohort study used data from the First National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Survival analyses were conducted using 9690 individuals 32 to 87 years of age and 1886 all-cause deaths during a 9.1-year follow-up. Corrections were made for the reputed regression-dilution bias by using the average BMI during the decade before follow-up as predictor. Corrections for the reputed reverse-causation bias were made by excluding participants with a history of serious illness. Attributable fractions were calculated and used to estimate excess deaths. RESULTS The uncorrected estimate of excess deaths attributable to obesity (BMI > or =30) was 41.9, using 18.5 to 25 kg/m(2) as ideal-weight category. Using average BMI as predictor increased the estimate to 93.3. Correcting for reverse-causation effects increased the estimate further to 131.1 (range, 93.3 to 169.0). The uncorrected hazard ratio, 1.25, was increased to 1.41 by using average BMI as predictor, and then to 2.40 by correcting for reverse causation. Using BMI 21 to 25 kg/m(2) and 23 to 25 kg/m(2) as ideal-weight categories increased the corrected estimates to 144.6 (range, 80.5 to 177.2) and 164.1 (range, 103.8 to 194.9), respectively. Larger increases were found for overweight and Grade 2 to 4 obesity (BMI > or =35 kg/m(2)). For overweight, the uncorrected estimate using 18.5 to 25 kg/m(2) as ideal-weight category was -88.3 and the corrected estimate using 23 to 25 kg/m(2) as ideal-weight category was 205.4 (range, 114.5 to 296.3). DISCUSSION Correcting for statistical biases and using higher ideal-weight categories increased the estimate of excess deaths attributable to obesity by approximately 400% and changed the negative estimate for overweight to a large positive estimate.
Collapse
Affiliation(s)
- James A Greenberg
- Department of Health and Nutrition Sciences, Brooklyn College of the City University of New York, 2900 Bedford Avenue, Brooklyn, NY 11210, USA.
| |
Collapse
|
20
|
Greenberg JA. Re: "Body mass index and incident ischemic heart disease in South Korean men". Am J Epidemiol 2006; 163:99. [PMID: 16282239 DOI: 10.1093/aje/kwj004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JCM. Hypertension Control as Predictor of Mortality in Treated Men and Women, Followed for up to 30 Years. Cardiovasc Drugs Ther 2005; 19:227-35. [PMID: 16142601 DOI: 10.1007/s10557-005-1643-0] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
PURPOSE To examine the prognosis of treated, hypertensive individuals in the Reykjavik Study. METHODS A population-based longitudinal study of 9328 men and 10 062 women. Subjects were included in the study during the period 1967-1996. Two groups of treated, hypertensive subjects were defined at baseline: with controlled blood pressure and with uncontrolled blood pressure. Main outcome measures were cardiovascular disease (CVD) mortality and all-cause mortality. RESULTS Of the hypertensive men 24.8% were treated, and of those 38.3% were controlled, and of the hypertensive women 45.3% were treated, and of those 52.7% were controlled. Comparing treated and uncontrolled (systolic blood pressure (SBP) > or =160 mmHg and/or diastolic blood pressure (DBP) > or =95 mmHg) versus treated and controlled hypertensive subjects, followed for up to 30 years, the uncontrolled men and women were at significantly higher risk of CVD mortality, hazard ratio (HR) = 1.47 (95% confidence interval (CI): 1.06-2.02) and HR 1.70 (CI: 1.23-2.36), respectively, showing the benefit of hypertension control. The risk of all-cause mortality was increased for treated, uncontrolled men and women, compared with those who were treated and controlled, but did not reach significance. When analyzing blood pressure as a continuous variable among treated, hypertensive subjects, SBP was a better predictor than DBP of CVD mortality and all-cause mortality in women. This was not the case in men. CONCLUSIONS Control of blood pressure among hypertensive-treated subjects at baseline was associated with a lower risk of CVD mortality during follow-up. SBP was the single best predictor of CVD mortality and all-cause mortality in treated women. The uncontrolled women were at a higher risk than the uncontrolled men.
Collapse
Affiliation(s)
- Larus S Gudmundsson
- Department of Pharmacology and Toxicology, University of Iceland, Hagi, Hofsvallagata 53, IS-107 Reykjavik, Iceland
| | | | | | | | | | | |
Collapse
|
22
|
Greenberg JA. What about statistical confounding? Am J Cardiol 2005; 95:1024. [PMID: 15820184 DOI: 10.1016/j.amjcard.2005.01.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2004] [Revised: 11/01/2004] [Accepted: 01/22/2005] [Indexed: 10/25/2022]
|
23
|
Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality. Hypertension 2005; 45:240-5. [PMID: 15596571 DOI: 10.1161/01.hyp.0000152079.04553.2c] [Citation(s) in RCA: 308] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The objective of this study was to elucidate the long-term prognostic significance of ambulatory blood pressure. Ambulatory and casual blood pressure values were obtained from 1332 subjects (872 women and 460 men) aged ≥40 years from the general population of a rural Japanese community. Survival was then followed for 14 370 patient years and analyzed by a Cox hazard model adjusted for possible confounding factors. There were 72 cardiovascular deaths during the 10.8-year follow-up. The relationship between 24-hour systolic blood pressure and the cardiovascular mortality risk was U-shaped in the first 5 years, then changed to J-shaped over the rest of the 10.8-year follow-up. After censoring the first 2 years of data, the risk flattened until it again increased for the fifth quintile of 24-hour systolic blood pressure for the 10.8-year follow-up period. For 24-hour diastolic blood pressure, the J-shaped relationship remained unchanged, regardless of follow-up duration and censoring. Ambulatory systolic blood pressure values consistently showed stronger predictive power for cardiovascular mortality risk than did casual systolic blood pressure in the 10.8-year follow-up data, whereas such relationships became more marked after censoring the first 2 years. When nighttime and daytime systolic blood pressure values were simultaneously included in the same Cox model, only nighttime blood pressure significantly predicted the cardiovascular mortality risk for the 10.8-year follow-up data. We conclude that the relationship between ambulatory systolic blood pressure and cardiovascular mortality is not U-shaped or J-shaped, and that nighttime blood pressure has better prognostic value than daytime blood pressure.
Collapse
Affiliation(s)
- Masahiro Kikuya
- Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Medicine and Pharmaceutical Science, Sendai, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
|
25
|
|